Kevin J. Garff

Kevin Garff practices at North Coast Surgery Center - Oceanside in Oceanside, California.

Kevin Garff's NPI, 1609258920, was assigned on June 23, 2015. Kevin Garff graduated from Spencer Fox Eccles School of Medicine in 2015. Kevin Garff holds California license A160988.

Kevin Garff's primary practice is North Coast Surgery Center - Oceanside, at 3903 Waring Road, Oceanside, CA 92056. The practice phone is (760) 940-0997.

Kevin Garff's primary practice is North Coast Surgery Center - Oceanside in Oceanside, California. Kevin Garff is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Kevin Garff to 4 more medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kevin Garff practices, 5 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Kevin Garff's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Kevin Garff is board certified in ophthalmology by the American Board of Ophthalmology. Kevin Garff is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Kevin Garff treats.

CMS data shows 4,612 Medicare services from Kevin Garff across 16 procedure codes in 2024, for 950 Medicare patients. Medicare paid $400,253 for them.

CMS counts 950 Medicare patients who saw Kevin Garff in 2024. The largest group is 75 to 84, with 423 patients. 72% of them have high cholesterol, and 62% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Kevin Garff's median patient age at 71, with 58% women.

In 2024, Kevin Garff wrote 746 Medicare Part D claims for 255 patients. 48% of them were for generic drugs. CMS names the drug for 657 of them, across 19 drugs with 11 or more claims each, at $84,325 in total drug cost. In 2023, CMS named 859 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Kevin Garff for performance year 2024, reported as part of a group. Kevin Garff accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 341 procedures of cataract surgery by Kevin Garff, more than 91% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Kevin Garff, published from 2015 to 2023. 2015 was the busiest year, with 2. The most frequent topics are Phacoemulsification, Cataract and High-Energy Shock Waves. Kevin Garff has published most often in J Cataract Refract Surg. Kevin Garff's most frequent co-authors are William Richter Barlow, MD, Judd Michael Cahoon, MD, PhD and Allison J. Chen, MD, MPH.

CMS Open Payments shows 100 general payments to Kevin Garff from 26 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 56% of the total. RxSight Inc paid the most, $1,232.

Kevin Garff graduated from Spencer Fox Eccles School of Medicine in 2015.

Kevin Garff is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.